2810002I04Rik Activators
2810002I04Rik Activators are a diverse array of chemical compounds that facilitate the enhancement of the protein's activity through a variety of signaling pathways. Forskolin, Isoproterenol, and Rolipram all work to increase intracellular cAMP levels, which, in turn, activate PKA. PKA activation could lead to phosphorylation events that enhance 2810002I04Rik activity either directly or through modulation of the protein's signaling partners. Similarly, the calcium ionophores Ionomycin and A23187 raise intracellular calcium levels, thereby activating calcium-dependent signaling pathways that could lead to the enhancement of 2810002I04Rik function. The PI3K inhibitor LY294002 and the MEK inhibitor U0126, by altering their respective pathways, may indirectly increase 2810002I04Rik activity by affecting the balance of intracellular signaling cascades.
2810002I04Rik Activators are a diverse array of chemical compounds that facilitate the enhancement of the protein's activity through a variety of signaling pathways. Forskolin, Isoproterenol, and Rolipram all work to increase intracellular cAMP levels, which, in turn, activate PKA. PKA activation could lead to phosphorylation events that enhance 2810002I04Rik activity either directly or through modulation of the protein's signaling partners. Similarly, the calcium ionophores Ionomycin and A23187 raise intracellular calcium levels, thereby activating calcium-dependent signaling pathways that could lead to the enhancement of 2810002I04Rik function. The PI3K inhibitor LY294002 and the MEK inhibitor U0126, by altering their respective pathways, may indirectly increase 2810002I04Rik activity by affecting the balance of intracellular signaling cascades. SB203580, by inhibiting p38 MAPK, and EGCG, through its broad-spectrum kinase inhibition, may also shift signaling dynamics to favor the activation of 2810002I04Rik.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA acts as a PKC activator. PKC-mediated phosphorylation can lead to changes in protein interactions and functions that may increase the functional activity of 2810002I04Rik through downstream effects. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, potentially enhancing 2810002I04Rik activity through calcium-dependent signaling pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore that increases intracellular calcium, promoting the activation of calcium-dependent proteins that could upregulate 2810002I04Rik activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. By inhibiting PI3K, downstream signaling pathways may be altered, potentially leading to an enhancement of 2810002I04Rik activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, and its use could shift signaling pathways in a way that indirectly enhances the functional activity of 2810002I04Rik. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a kinase inhibitor with a broad range of targets. Its action may facilitate the enhancement of 2810002I04Rik by reducing competitive signaling pathways. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast is another PDE5 inhibitor that may increase cGMP levels, thereby potentially enhancing the functional activity of 2810002I04Rik through PKG-mediated signaling pathways. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a PDE4 inhibitor that increases cAMP levels, which could enhance 2810002I04Rik activity by activating PKA and affecting downstream signaling pathways. | ||||||